Vietnam is aiming to attract overseas investment to encourage domestic drug development through the amended 2016 Law on ...

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft ...

Clinical operations teams can expect a high return on investments in AI in the next 5–10 years, according to speakers at ...

IPA has entered a strategic partnership with Ribopro aiming to transform therapeutic antibody discovery and development.

Last month, the NICE endorsed Casgevy for use in the NHS under a managed access scheme to treat sickle cell disease.

The FDA has granted fast track designation to Pyxis oncology’s PYX-201 for the treatment of adults with R/M HNSCC.

Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing ...

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Eikon’s lead candidate EIK1001 is being investigated for melanoma in combination with MSD’s Keytruda in a Phase III trial.

Eli Lilly (Lilly) has agreed to make a $10m upfront payment for full worldwide rights to San Diego-based Organovo Holdings’ ...

RedHill has signed an exclusive licensing agreement with Hyloris for the global development and commercialisation of RHB-102 ...

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Grin Therapeutics’ radiprodil.